⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pipecolic Acid SCHEMBL22016 | 1.00 | — | — | |
| Pipecolic Acid SCHEMBL1002076 | 1.00 | BLM (0.45) | — | |
| Pipecolic Acid SCHEMBL40185 | 1.00 | — | — | |
| Pipecolic Acid SCHEMBL4758702 | 1.00 | BLM (0.45) | — | |
| Pipecolic Acid SCHEMBL1078450 | 1.00 | BLM (0.45) | — | |
| Pipecolic Acid SCHEMBL58642 | 1.00 | — | — | |
| Pipecolic Acid SCHEMBL29479229 | 1.00 | — | — | |
| SCHEMBL23997628 | 0.98 | MEN1 (0.43) | — | |
| SCHEMBL6235834 | 0.98 | MEN1 (0.43) | — | |
| SCHEMBL5568760 | 0.98 | MEN1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4504970-A1 | COMPOSITIONS AND ANALYSIS OF DEPHOSPHORYLATED OLIGORIBONUCLEOTIDES | New England Biolabs, Inc. (US) | 2025-02-12 | — | — | EP | disclosed |
| US-12173368-B2 | Compositions and analysis of dephosphorylated oligoribonucleotides | NEW ENGLAND BIOLABS, INC. (US) | 2024-12-24 | — | — | US | disclosed |
| US-20240301485-A1 | Compositions and Analysis of Dephosphorylated Oligoribonucleotides | NEW ENGLAND BIOLABS, INC. (US) | 2024-09-12 | — | — | US | disclosed |
| WO-2023197015-A1 | COMPOSITIONS AND ANALYSIS OF DEPHOSPHORYLATED OLIGORIBONUCLEOTIDES | NEW ENGLAND BIOLABS, INC. (US) | 2023-10-12 | — | — | WO | disclosed |
| US-20230287489-A1 | Compositions and Analysis of Dephosphorylated Oligoribonucleotides | NEW ENGLAND BIOLABS, INC. (US) | 2023-09-14 | — | — | US | disclosed |